Topiramate and Pregabalin in Lumbar Radicular Pain. Is Topiramate a better option?

  • Asim Ishfaq Department of Neurosurgery CMH Lahore
  • Javaria Ashraf
  • Aimen Haider
Keywords: Pain, Topiramate, Pregabalin

Abstract

Abstract

Objective: To compare the efficacy of two anticonvulsant drugs topiramate and pregabalin on lumbar radicular pain and to find out whether topiramate is a better option or not.

Study design: Experimental study.

Place and Duration: Department of Neurosurgery, Combined Military Hospital Lahore. January 2020 - March 2020.

Patients and Methods: 60 patients of both gender divided in two groups of 30 each were included. Patients were assessed based on subjective impairment scale of oswestry disability index. Maximum score was calculated in percentage with higher score pointing to greater disability. Both drugs were given in low starting once daily dose, 75 mg for pregabalin and 25 mg for topiramate for two weeks followed by twice daily dose for two more weeks in patients not getting pain relief. 

Results: Male to female ratio of 4:1 in both groups. Age range of 27-77 years (41.5+12.45) for pregabalin and 22-74 years (41.6+14.6) for topiramate group. Baseline demographics and pre drug pain measurement index were identical amongst two groups. Oswestry disability index was 49.2+18.3 pre drug and post drug 41+16.4 for pregabalin (p<0.01). For topiramate it was 43.6+37.9 pre drug and 37.9+17.3 post drug (p <0.01).

Conclusion:    Both pregabalin and topiramate are effective in radicular pain management,  and topiramate is not better but still a viable option as an alternative to pregabalin.

References

1. Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, et al. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Clin Ther. 2010; 32(14): 2370–85.
2. Khoromi S, Patsalides A, Parada S, Salehi V, Meegan JM, Max MB. Topiramate in chronic lumbar radicular pain. J Pain. 2005; 6(12): 829-836.
3. Ogawa S, Komatsu M, Ohno S, Yamane H, Hayakawa K. Interim report of drug use investigations of pregabalin (Lyrica) Progress in Medicine. 2013;33(10):2159–2171.
4. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week randomized double-blind multicenter placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005; 1(15): 254–63.
5. Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004; 63 :865-73.
6. Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leitberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. Clin J Pain. 2006 Jul-Aug; 22(6): 526-31.
7. Khoromi S, Patsalides A, Parada S, Salehi V, Meegan JM, Max MB. Topiramate in chronic lumbar radicular pain. J Pain. 2005; 6(12): 829-836.
8. Tarulli AW, Raynor EM. Lumbosacral radiculopathy. Neurol Clin. 2007; 25(2): 387-405.
9. Berry JA, Elia C, Saini HS, Miulli DE. A Review of Lumbar Radiculopathy, Diagnosis, and Treatment. Cureus. 2019; 11(10): e5934.
10. Gugliotta M, da Costa BR, Dabis E, Theiler R, Juni P, Riechenbach S, et al. Surgical versus conservative treatment for lumbar disc herniation: a prospective cohort study. BMJ Open. 2016; 6(12): e 012938.
11. Atlas SJ, Keller RB, Wu YA, Deyo RA, Singer DE. Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976). 2005; 30(8): 927-935.
12. Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Anderson M, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018; 27(1): 60-75.
13. Tubach F, Beauté J, Leclerc A. Natural history and prognostic indicators of sciatica. J Clin Epidemiol. 2004;57(2):174-179.
14. Konstantinou K, Dunn KM, Ogollah R, Vogel S, Hay EM; ATLAS study research team. Characteristics of patients with low back and leg pain seeking treatment in primary care: baseline results from the ATLAS cohort study. BMC Musculoskelet Disord. 2015 Nov 4; 16: 332.
15. Hofstee DJ, Gijtenbeek JM, Hoogland PH, Houwelingen HC, Kloet A, Lotters F, et al. Westeinde sciatica trial: randomized controlled study of bed rest and physiotherapy for acute sciatica. J Neurosurg. 2002;96(1 Suppl):45-49.
16. Peul WC, Brand R, Thomeer RT, Koes BW. Influence of gender and other prognostic factors on outcome of sciatica. Pain. 2008; 138(1): 180-191.
17. Brodke DS, Goz V, Lawrence BD, Spiker WR, Neese A, Hung M. Oswestry Disability Index; a psychometric analysis with 1610 patients. Spine J. 2017; 17(3): 321-327.
18. Azimi P, Benzel E. The Low-Back Outcome Scale and the Oswestry disability index: are they reflective of patient satisfaction after discectomy? A cross sectional study. J Spine Surg. 2017; 3(4): 554-560.
19. Khoromi S, Patsalides A, Parada S, Salehi V, Meegan JM, Max MB. Topiramate in chronic lumbar radicular pain. J Pain. 2005; 6(12): 829-836.
20. Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, et al. Trial of Pregabalin for Acute and Chronic Sciatica. N Engl J Med. 2017; 376(12): 1111-1120.
Published
2020-12-30
How to Cite
1.
Ishfaq A, Ashraf J, Haider A. Topiramate and Pregabalin in Lumbar Radicular Pain. Is Topiramate a better option?. JRMC [Internet]. 30Dec.2020 [cited 23Oct.2021];24(4):374-7. Available from: http://journalrmc.com/index.php/JRMC/article/view/1463